CoChat

Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia

Open access
Lucarelli, G., Isgro, A., Sodani, P., Gaziev, J. · 2012 · Cold Spring Harbor Perspectives in Medicine

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

The globally widespread single-gene disorders β-thalassemia and sickle cell anemia (SCA) can only be cured by allogeneic hematopoietic stem cell transplantation (HSCT). HSCT treatment of thalassemia has substantially improved over the last two decades, with advancements in preventive strategies, control of transplant-related complications, and preparative regimens. A risk class-based transplantation approach results in disease-free survival probabilities of 90%, 84%, and 78% for class 1, 2, and 3 thalassemia patients, respectively. Because of disease advancement, adult thalassemia patients have a higher risk for transplant-related toxicity and a 65% cure rate. Patients without matched donors could benefit from haploidentical mother-to-child transplantation. There is a high cure rate for children with SCA who receive HSCT following myeloablative conditioning protocols. Novel non-myeloablative transplantation protocols could make HSCT available to adult SCA patients who were previously excluded from allogeneic stem cell transplantation.

Overview

Integrity signals

Registry

Crossref · 10.1101/cshperspect.a011825

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 52 references

Cited by

See all 166

Metadata

Authors
Lucarelli, G., Isgro, A., Sodani, P., & Gaziev, J.
Affiliations
University of Rome Tor Vergata (IT)
Corresponding author
Lucarelli, G.
Venue
Cold Spring Harbor Perspectives in Medicine
Published
2012-04-04
Volume
2
Issue
5
Pages
a011825-a011825
ISSN
2157-1422 (ISSN-L)
OpenAlex
W2113456470
Cited by
166
References
50
Citations by year
2026: 7 · 2025: 9 · 2024: 14 · 2023: 16 · 2022: 12 · 2021: 14 · 2020: 14 · 2019: 12 · 2018: 10 · 2017: 11 · 2016: 12 · 2015: 10 · 2014: 16 · 2013: 6 · 2012: 2
Type
posted content
Language
en
Open access
Locations
  • Cold Spring Harbor Perspectives in Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Hematology › Blood transfusion and management
Keywords
hematopoietic stem cell transplantation, thalassemia, sickle cell disease, allogeneic transplantation, risk stratification, transplant toxicity, haploidentical transplantation, myeloablative conditioning, nonmyeloablative conditioning, disease-free survival
MeSH terms
Adult, Anemia, Sickle Cell, Graft vs Host Disease, Humans, Thalassemia, Hematopoietic Stem Cell Transplantation, Living Donors, Myeloablative Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia. https://app.cochat.ai/papers/10.1101/cshperspect.a011825
The paper
Lucarelli, G., Isgro, A., Sodani, P., & Gaziev, J. (2012). Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia. Cold Spring Harbor Perspectives in Medicine. https://doi.org/10.1101/cshperspect.a011825

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.